Vitamin e anticoagulant properties
Pro Research Analysisby 
Searched over 200M research papers
Vitamin E Anticoagulant Properties: Mechanisms and Clinical Implications
Mechanisms of Vitamin E’s Anticoagulant Effects
Vitamin E, particularly in its quinone form, acts as a potent anticoagulant by inhibiting the vitamin K-dependent carboxylase enzyme, which is essential for blood clotting. This inhibition occurs through the attachment of the enzyme’s active site thiol groups to methyl groups on vitamin E quinone, disrupting the normal clotting process . In contrast, the reduced form of vitamin E (alpha-tocopherol) shows only modest anticlotting activity .
Vitamin E also affects platelet function. It inhibits platelet aggregation and reduces the exposure of phosphatidylserine (PS) on the platelet surface, which is a key step in the coagulation cascade. This effect is partly due to increased activity of aminophospholipid translocase (APLT), which moves PS from the outer to the inner membrane leaflet, thereby reducing the procoagulant surface available for clot formation . Additionally, vitamin E’s inhibition of platelet aggregation is linked to the suppression of protein kinase C (PKC) activity, and this effect is independent of its antioxidant properties .
Vitamin E and Bleeding Risk
Clinical studies have shown that higher serum levels of vitamin E are associated with an increased risk of bleeding in patients receiving oral anticoagulant therapy, such as warfarin. Patients with higher vitamin E levels experienced more bleeding events, including both minor and major hemorrhages . This suggests that vitamin E can amplify the effects of anticoagulant drugs, increasing the risk of bleeding complications 56.
High-dose vitamin E supplementation has also been shown to increase levels of undercarboxylated prothrombin (PIVKA-II), a marker of poor vitamin K status, in adults not taking anticoagulants. This finding indicates that vitamin E may antagonize vitamin K, further impairing the blood clotting process and potentially increasing bleeding risk even in healthy individuals .
Vitamin E in Cardiovascular Disease and Hemodialysis
Vitamin E’s anticoagulant and antithrombotic properties have been studied in the context of cardiovascular disease (CVD). While experimental studies suggest that vitamin E can modulate platelet function and the clotting system, large interventional trials have not consistently shown a benefit in preventing cardiovascular events . The balance between antioxidant and anticoagulant effects is complex, and excessive supplementation may lead to adverse outcomes, including increased bleeding and hemorrhagic stroke, especially in individuals with pre-existing health conditions 36.
In hemodialysis, vitamin E-coated membranes have been developed to reduce clotting in the extracorporeal circuit, offering an alternative to systemic anticoagulation for patients at high risk of bleeding .
Conclusion
Vitamin E exhibits anticoagulant properties through multiple mechanisms, including inhibition of vitamin K-dependent clotting factors, suppression of platelet procoagulant activity, and antagonism of vitamin K. While these effects may offer benefits in certain clinical settings, high-dose vitamin E supplementation can increase bleeding risk, particularly when combined with other anticoagulant therapies. Careful consideration and further research are needed to balance the potential benefits and risks of vitamin E, especially in populations vulnerable to bleeding complications.
Sources and full results
Most relevant research papers on this topic